Priority Date: 23.11.11 (US 201161563507P)

NUCLEIC ACID VACCINES AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE

  • Application ID: EP12851895
  • Status: GRANT OF PATENT INTENDED

Attorney

Employment test 11 - 50 employees
Company dna eip1
operating since 2009
Headquarter in London and 4 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61, C07, and C12 is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 128 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 23.11.2011 - Priority Date (US 201161563507P)
  • 30.05.2013 - Publication A1 (WO2013078299)
  • 01.10.2014 - Publication A1 (EP2782597)